Various reagents: albacyet A1 cells, albacyte b cells, albacyte A2 cells, albacyte screening cells, ablacyte ABY identification panel 'a', IGG sensitized red cells, and coated red blood cells.
Ended Awarded Last action
- Contract number
- 75N90021F00019
- Awardee
-
Alba Bioscience, Inc. UEI V6KNKL6BDHL7
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $18,919
Award facts
- Contract value 100% obligated
- $18,919.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Newtown, PA 18940, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract 75N90021F00019?
75N90021F00019 was awarded to Alba Bioscience, Inc. by NIH Clinical Center (National Institutes of Health) on January 12, 2021.
How much is contract 75N90021F00019 worth?
The government has obligated $18,919 on 75N90021F00019.
Is contract 75N90021F00019 an order under another contract?
Yes. 75N90021F00019 is a delivery order under V797P2050D, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 75N90021F00019 competed?
The extent of competition for 75N90021F00019 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award